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Predictive factors for the indeterminate result on the
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J.-H. Baek, C.O. Kim, J.Y. Choi, Y.G. Song, J.M. Kim
Yonsei University College of Medicine, Seoul, Korea, Repub-
lic of
Background: QuantiFERON-TB Gold In-Tube (QFT-G IT)
test is recommended for screening of latent tuberculosis.
However, this can reveal the indeterminate results, espe-
cially in the immunocompromised patients. Therefore, we
investigated the predictive factors that can inﬂuence the
indeterminate results on QFT-G IT.
Methods: We performed a retrospective case-control
study with 144 cases with the indeterminate results on
QFT-G IT from October 2006 to March 2009 at Severance
Hospital. The controls with the positive or negative results
were selected by matching 1:1 with the case for date of QFT-
G IT assay. An indeterminate result was considered when
the level in both the tuberculosis antigen and mitogen tube
was less than 0.35 IU/ml, or the level in the nil tube was
higher than 8.0 IU/ml. Through retrospective review of med-
ical records, age, gender, total lymphocyte count at the
QFT-G IT assay, underlying diseases, and medical conditions
which can inﬂuence the immune function were collected
as covariates. The predictive factors for the indeterminate
results on QFT-G IT were assessed by multivariate logistic
regression models.
Results: Age and gender did not show the signiﬁcant dif-
ferences between case and control patients (p = 0.105 and
0.906). The percentage of patients with hematologic malig-
nancy (19.4% vs. 11.1%, p = 0.049), chronic renal disease
(22.2% vs. 9.7%, p = 0.004), and autoimmune disease (16.0%
vs. 6.3%, p = 0.009) in the case group were the signiﬁcantly
higher than those in the control group. Also, the case group
had the signiﬁcantly higher percentage of steroid use (16.0%
vs. 8.3%, p = 0.047) and solid organ transplantation (11.1%
vs. 2.1%, p = 0.002) than the control group. The total lym-
phocyte count was the signiﬁcantly lower in the case group
than in the control group (median [interquartile range], 540
[220—1,030] vs. 1,370 [870—1,970], p < 0.001). In the ﬁnal
regression model, clinical factors associated with the inde-
terminate results were chronic renal disease (odds ratio [OR]
2.26, 95% conﬁdential interval [CI] 1.03—4.94, p = 0.041),
autoimmune disease (OR 3.99, 95% CI 1.65—9.66, p = 0.002),
and solid organ transplantation (OR 5.06, 95% CI 1.30—19.73,
p = 0.020).
Conclusion: The patients with lower lymphocyte counts
or immunosuppressive condition showed the higher pos-
sibility of the indeterminate results on QFT-G IT assay.
Therefore, the combined assay such as tuberculin skin test
and T-SOPT TB with QFT-G IT may be helpful to screen the
latent tuberculosis in the patients with these conditions.
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retrospective study to assess treatment outcomes
mong TB patients taking DOTS treatment in South India
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acIntyre1, D. Mathai2, K. John2
University of New South Wales, Sydney, Australia
Christian Medical College and Hospital, Vellore, India
Background: In spite of the wide implementation of
irectly Observed Treatment Short course (DOTS) strategy in
ndia, Tuberculosis (TB) still remains a major public health
roblem in the country. There is a considerable doubt about
he effectiveness of DOTS program in TB control in the coun-
ry; a retrospective analysis was conducted to assess the
esponse to treatment among individuals who take TB med-
cations through the DOTS program in South India.
Methods: Retrospective chart review of 136 consecutive
B cases who sought care at the DOTS clinic in Christian
edical College and Hospital, Vellore, South India during the
eriod October 2008 to October 2009.
Results: Of 136 patients who sought care there were 85
ales (63%), median age was 39 years, 15 tested positive
or HIV, 68 negative for HIV and 52 of them had no HIV sta-
us revealed. Of the total, 91 (67.4%) had pulmonary TB and
3 (32%) had extra pulmonary TB. Almost 104 (77%) of them
ere new cases of TB, 7 (5%) were defaulters from prior
B treatment. 99 of them had their sputum tested for AFB
f which, 76 tested positive for AFB and the rest had nega-
ive smear results. There were no reports available for the
est. At the end of intensive phase of treatment there were
early 18 (27%) of them who remained smear positive in
pite of supervised treatment. Similarly at the end of two
onths continuous phase there were 2 (8%) of them who still
emained smear positive. There were a total of 6 patients
ho were completing 6 month DOTS therapy, among which
ne person had converted from smear negative to smear
ositive at the end of treatment.
Conclusion: Nearly one fourth of the cases remained
mear positive at the end of intensive phase, in spite of
upervised treatment, in our study sample. Cases which do
ot respond to treatment should be tested for drug resis-
ance and susceptibility at the earliest. Unless there is rapid
iagnosis and treatment of treatment failure and relapse
ases there won’t be any progress in our efforts to control
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opulation-based investigation on molecular characteri-
ation of Fluoroquinolones resistance of Mycobacterium
uberculosis in rural area of eastern China
. Xu ∗, Y. Hu, W. Jiang, W. Wang
School of Public Health, Fudan University, Shanghai, China
Background: Extensive use of ﬂuoroquinolones in treat-
ng numerous bacterial infections might select for resistant
trains of Mycobacterium tuberculosis (M.TB), especially in
hina where uses of ﬂuoroquinolones in treating TB have
ot been standardized yet. The present study was to investi-
